BTIG Reiterates Buy on Edwards Lifesciences, Maintains $110 Price Target

Benzinga · 2d ago
BTIG analyst Marie Thibault reiterates Edwards Lifesciences (NYSE:EW) with a Buy and maintains $110 price target.